Infectious olecranon and patellar bursitis: short-course adjuvant antibiotic therapy is not a risk factor for recurrence in adult hospitalized patients | Zendy

C. Perez | Zendy; Angela Huttner | Zendy; Mathieu Assal | Zendy; Louis Bernard | Zendy; Daniel Lew | Zendy; Pierre Hoffmeyer | Zendy; İlker Uçkay | Zendy

Open Access

Infectious olecranon and patellar bursitis: short-course adjuvant antibiotic therapy is not a risk factor for recurrence in adult hospitalized patients

Author(s) -

C. Perez,

Angela Huttner,

Mathieu Assal,

Louis Bernard,

Daniel Lew,

Pierre Hoffmeyer,

İlker Uçkay

Publication year - 2010

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkq043

Subject(s) - bursectomy , medicine , bursitis , antibiotic therapy , epidemiology , risk factor , antibiotics , surgery , immunology , antibody , microbiology and biotechnology , biology

No evidence-based recommendations exist for the management of infectious bursitis. We examined epidemiology and risk factors for recurrence of septic bursitis. Specifically, we compared outcome in patients receiving bursectomy plus short-course adjuvant antibiotic therapy (<or=7 days) with that of patients receiving bursectomy plus longer-course antibiotic therapy (>7 days).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research